2015 WORLDWIDE MARKETS AND EMERGING TECHNOLOGIES FOR POINT-OF-CARE TESTING

307 Pages | 129 Exhibits | 2015 Analysis | Forecasts Through 2019 Product Family: Market Reports




OVERVIEW:
The market for point-of-care (POC) diagnostic products comprises 28% of the total in-vitro diagnostics market. The market is projected to grow at a considerably slower rate than the overall IVD market over the 2014-2019 interval, primarily due to stagnant sales in the whole blood glucose self-testing segment, which accounts for more than half (53%) of the total market. However, most other segments of the POC diagnostics market are growing at rates well in excess of the overall POC market, and in excess of the rate for the total IVD market. Point of care testing encompasses a wide range of diagnostic applications and a wide range of product types. Examples are blood gas tests performed using handheld analyzers at the hospital bedside, whole blood glucose and pregnancy self-testing, rapid infectious disease tests performed in the physician's office or emergency department, and cardiac marker tests performed in the chest pain clinic. In this report, the POC market is segmented into three primary categories, including hospital bedside testing products, home and self-testing products, and physician's office lab products.

COVERAGE INCLUDES:

•    Trends in the global clinical diagnostics market and 2013-2019 market analysis by segment
•    Factors driving growth in point-of-care testing
•    Hospital POC testing market analysis, including critical care testing, bedside whole blood glucose monitoring, rapid
      tests, POC coagulation testing, POC cardiac markers, and drugs of abuse rapid tests
•    Self-testing market assessment, including whole blood glucose monitoring, coagulation self-testing, pregnancy and
      fertility testing, home infectious disease and drugs of abuse testing, home cholesterol testing.
•    Physician's office laboratory market analysis by segment
•    New products and technologies under development for point-of-care testing
•    Current and forecast market size (2014-2019), pricing trends, and analysis of competitive factors
•    Key business transactions, competitor strategies, marketing and distribution strategies
•    In-depth profiles of 24 companies and coverage of 412 competitors


TABLE OF CONTENTS:
EXECUTIVE SUMMARY

Exhibit ES-1: Worldwide POC In-Vitro Diagnostics Market, 2013-2019
Exhibit ES-2: Worldwide POC Test Volume Distribution by Site, 2013-2019
Exhibit ES-3: Worldwide POC Diagnostics Market Trend by Test Site, 2013-2019
Exhibit ES-4: Worldwide Hospital POC Testing Products Market by Segment, 2013-2019
Exhibit ES-5: Worldwide Home/Self-Testing Products Market, 2013-2019
Exhibit ES-6: Global Physician's Office Laboratory Market by Test Segment
Exhibit ES-7: Comparison of POC Market Segment Growth Rates, 2014-2019
Exhibit ES-8: 2014 POC IVD Suppliers' Sales and Market Share

1. MARKET OVERVIEW

1.1 Trends in the Global Clinical Diagnostics Market
1.2 Clinical Diagnostics Market and Technology Trends by Segment
	1.2.1 Clinical Chemistry
	1.2.2 Immunodiagnostics
	1.2.3 Hematology and Coagulation
	1.2.4 Microbiology
	1.2.5 Molecular Diagnostics
1.3 Trends in Laboratory Restructuring and the Organization of Testing
1.4 Factors Driving the Adoption of Point-of-Care Testing Regulatory Trends Impacting the Use of Point-of-Care Testing
1.6 Cost and Reimbursement Issues in Point-of-Care Testing
1.7 Quality Control and Quality Assurance Issues in Point-of-Care Testing
1.8 Trends in Self-Monitoring, Disease Screening, Wellness Testing, Risk Assessment and Preventative Testing
1.9 Changes in the Site of Health Care Delivery

Exhibit 1.1: Global Medical Device and Diagnostics Market, 2013-2019
Exhibit 1.2: Trends in Population 65 and Older and Health Expenditures, Selected Countries
Exhibit 1.3: U.S. Surgical Procedure Volume by Site, 2013
Exhibit 1.4: Expansion of Clinical Lab Automation in the U.S.
Exhibit 1.5: Changes to the Clinical Laboratory Fee Schedule in the U.S., 2000-2014
Exhibit 1.6: Trends in the Site of Laboratory-Based Testing in the U.S., 2002-2014
Exhibit 1.7: Worldwide Clinical Diagnostics Market by Segment, 2013-2019
Exhibit 1.8: Worldwide Clinical Diagnostic Products Market by Region
Exhibit 1.9: Worldwide Clinical Chemistry Market, 2013-2019
Exhibit 1.10: 2014 Worldwide Immunoassay Reagent and Supply Market by Segment
Exhibit 1.11: Worldwide Hematology/Coagulation Testing Products Market, 2013-2019
Exhibit 1.12: Worldwide Microbiology Market by Segment
Exhibit 1.13: Worldwide Molecular Diagnostics Market by Application Segment, 2013-2019
Exhibit 1.14: Number of CLIA-Registered U.S. Clinical Laboratories by Type, 2000-2014
Exhibit 1.15: Key Factors Driving Adoption of POC Testing
Exhibit 1.16: Trends in CLIA-Waived Labs vs. Total Labs in the U.S., 2004-2014
Exhibit 1.17: Waived Analyte Tests Performed in Clinical Labs
Exhibit 1.18: Waived Analyte Tests Performed by Type of Lab
Exhibit 1.19: Segmentation of Healthcare Costs in the U.S.
Exhibit 1.20: Historical Trends in the Number of Hospitals, Hospital Beds, Hospital Admissions, and Average Hospital Stay
Exhibit 1.21: Trend in the Number of Retail Medical Clinics in the U.S.

2. HOSPITAL-BASED POINT-OF-CARE TESTING PRODUCTS

2.1 Hospital Diagnostic Testing Environment
2.2 Bedside Critical Care Testing Products Market
	2.2.1 Trends in POC Critical Care Test Volume and Equipment Installed Base
	2.2.2 Existing POC Critical Care Testing Products
	2.2.3 New Technologies Under Development for POC Bedside Critical Care Testing
	2.2.4 Bedside Critical Care Testing Market Analysis and Forecast
	2.2.5 Bedside Critical Care Testing Product Suppliers' Sales and Market Shares
	2.2.6 Drivers and Limiters of the Hospital POC Critical Care Testing Products Market
2.3 Hospital Bedside Hemostasis Testing Products Market
	2.3.1 Trends in POC Hemostasis Test Volume and Equipment Installed Base
	2.3.2 Existing POC Hemostasis Testing Products
	2.3.3 New Products and Technologies Under Development for POC Hemostasis Testing
	2.3.4 Hospital-Based POC Hemostasis Testing Market Analysis and Forecast
	2.3.5 Hospital-Based POC Hemostasis Testing Product Suppliers' Sales and Market Shares
	2.3.6 Drivers and Limiters of the Hospital POC Hemostasis Testing Products Market
2.4 Bedside/POC Drugs of Abuse Testing Products Market
	2.4.1 Trends in Bedside/POC Drugs of Abuse Testing
	2.4.2 Existing Bedside/POC Drugs of Abuse Testing Products
	2.4.3 POC Drugs of Abuse Testing Market Analysis and Forecast
	2.4.4 POC Drugs of Abuse Testing Product Suppliers' Sales and Market Shares
	2.4.5 Drivers and Limiters of the Hospital POC Drugs of Abuse Testing Products Market
2.5 POC Cardiac Marker Testing Products Market Analysis
	2.5.1 Trends in POC Cardiac Marker Testing
	2.5.2 POC Cardiac Marker Products Under Development
	2.5.3 POC Cardiac Marker Market Analysis and Forecast
	2.5.4 POC Cardiac Marker Product Suppliers' Sales and Market Shares
	2.5.5 Drivers and Limiters of the POC Cardiac Marker Testing Products Market
2.6 Other Bedside/POC Testing Products Markets
	2.6.1 POC Infectious Disease Testing Products, Market Analysis and Suppliers
	2.6.2 POC Products and Markets for Hemoglobin and Hematocrit Testing
	2.6.3 Hospital and Institutional Bedside Whole Blood Glucose Monitoring Market
		2.6.3.1 Products for Hospital/Institutional Bedside Whole Blood Glucose Monitoring
		2.6.3.2 Hospital/Institutional Bedside Whole Blood Glucose Monitoring Market Analysis
		2.6.3.3 Drivers and Limiters of the Hospital/Institutional Bedside Whole Blood Glucose Monitoring Products Market
		2.6.3.4 Other Hospital Bedside POC Testing Products

Exhibit 2.1: Hospital Sites for Clinical Diagnostic Testing in the U.S.
Exhibit 2.2: Clinical Testing Site Distribution for Selected Countries
Exhibit 2.3: Trends in Global Hospital-Based POC In-Vitro Diagnostic Test Volume
Exhibit 2.4: Trends in Worldwide Hospital POC Test Volume by Analyte Segment
Exhibit 2.5: Trends in Emergency Room Visits and Number of Emergency Rooms in Community Hospitals in the U.S.
Exhibit 2.6: Distribution of Hospital-Based POC Test Volume by Site
Exhibit 2.7: Clinical Factors Driving Usage of Point-of-Care Testing
Exhibit 2.8: Trends in Worldwide POC Blood Gas/Electrolyte/Metabolite Test Volume and Instrument Installed Base
Exhibit 2.9: Existing POC Critical Care Testing Products
Exhibit 2.10: Development-Stage POC Critical Care Testing Products
Exhibit 2.11: Worldwide Market for Hospital POC Critical Care Testing Products
Exhibit 2.12: Worldwide Market for POC Single-Test Cartridge Critical Care Testing Products
Exhibit 2.13: Worldwide Market for POC Multi-Test Cartridge Critical Care Testing Products
Exhibit 2.14: Laboratory Versus POC Critical Care Testing Products Market
Exhibit 2.15: 2014 Worldwide Sales and Market Share for Leading Suppliers of POC Critical Care Testing Products
Exhibit 2.16: 2014 Worldwide Sales and Market Share for Leading Suppliers of POC Critical Care Testing Products by Region
Exhibit 2.17: Diseases and Procedures with Indications for Anti-coagulation Therapy
Exhibit 2.18: Trends in Diagnosis of Atrial Fibrillation in U.S. Hospital Patients, 1996-2006
Exhibit 2.19: Platelet Aggregation/Platelet Function Test Volume Trend in the U.S. Medicare Population, 2002-2013
Exhibit 2.20: Trends in Worldwide POC Hemostasis Test Volume and Instrument Installed Base
Exhibit 2.21: Existing POC Hemostasis Testing Products
Exhibit 2.22: Worldwide Market for Hospital POC Hemostasis Testing Products
Exhibit 2.23: Worldwide Market for Hospital POC Hemostasis Testing Products by Segment
Exhibit 2.24: Laboratory Versus Hospital-Based POC and Self-Test Hemostasis Products Market, 2013-2019
Exhibit 2.25: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemostasis Testing Products
Exhibit 2.26: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemostasis Testing Products by Region
Exhibit 2.27: CMS Decision Memorandum Observations
Exhibit 2.28: Number and Percentage of U.S. ED Visits Involving Illicit Drug Use, 2006 and 2011
Exhibit 2.29: Existing Hospital POC Drugs of Abuse Testing Products
Exhibit 2.30: Worldwide Market for POC Drugs-of-Abuse Testing Products (Hospital Segment)
Exhibit 2.31: Worldwide Market for Laboratory Versus POC Drugs-of-Abuse Testing Products (Hospital Segment)
Exhibit 2.32: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Drugs-of-Abuse Testing Products by Region
Exhibit 2.33: Analytical Characteristics of Cardiac Troponin I and T Assays for POC and Laboratory Use
Exhibit 2.34: Existing Hospital POC Cardiac Marker Testing Products
Exhibit 2.35: New POC Cardiac Marker Testing Products Under Development
Exhibit 2.36: Worldwide Market for POC Cardiac Marker Products
Exhibit 2.37: Worldwide Market for Laboratory Versus POC Cardiac Marker Products
Exhibit 2.38: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Cardiac Marker Products by Region
Exhibit 2.39: Existing Hospital POC Infectious Disease Testing Products
Exhibit 2.40: Worldwide Market for Hospital POC Infectious Disease Testing Products
Exhibit 2.41: Worldwide Market for Laboratory Versus Hospital POC Infectious Disease Testing Products
Exhibit 2.42: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Infectious Disease Testing Products by Region
Exhibit 2.43: Worldwide Market for Hospital POC Hemoglobin and Hematocrit Testing Products
Exhibit 2.44: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Hemoglobin and Hematocrit Testing Products by Region
Exhibit 2.45: Existing Hospital POC Whole Blood Glucose Monitoring Products
Exhibit 2.46: Worldwide Market for Hospital POC Whole Blood Glucose Products by Segment
Exhibit 2.47: Total Worldwide Market for Hospital POC Whole Blood Glucose Testing Products
Exhibit 2.48: 2014 Worldwide Sales and Market Share for Leading Suppliers of Hospital POC Whole Blood Glucose Testing Products by Region

CHAPTER 3: HOME AND SELF-TESTING PRODUCTS

3.1 Whole Blood Glucose Self-Testing Products Market
	3.1.1 Existing Whole Blood Glucose Self-Testing Products
	3.1.2 Development-Stage Whole Blood Glucose Self-Testing Products
		3.1.2.1 Integrated Glucose Testing Devices
		3.1.2.2 Implantable Glucose Monitors
		3.1.2.3 Non-Invasive Glucose Monitoring
	3.1.3 Whole Blood Glucose Self-Testing Products Market Analysis and Forecast
	3.1.4 Whole Blood Glucose Self-Testing Product Suppliers' Sales and Market Shares
	3.1.5 Drivers and Limiters of the Whole Blood Glucose Self-Testing Products Market
3.2 OTC Pregnancy and Fertility Testing Products Market
	3.2.1 Trends in Home Pregnancy and Fertility Testing
	3.2.2 Existing Products for Home Pregnancy and Fertility Testing
	3.2.3 New Products Under Development for Home Pregnancy and Fertility Testing
	3.2.4 OTC Pregnancy and Fertility Testing Products Market Analysis and Forecast
	3.2.5 OTC Pregnancy and Fertility Testing Product Suppliers' Sales and Market Shares
	3.2.6 Drivers and Limiters of the OTC Pregnancy and Fertility Testing Products Market
3.3 Markets for Other Home and Self-Testing Products
	3.3.1 Cholesterol Self-Testing
	3.3.2 Fecal Occult Blood Testing
	3.3.3 Home Drugs of Abuse Testing
	3.3.4 Coagulation Self-Testing
	3.3.5 Infectious Disease Self-Testing
	3.3.6 Home Heart Failure Monitoring

Exhibit 3.1: Global Diabetes Prevalence Trends According to the World Health Organization and the International Diabetes Federation
Exhibit 3.2: Frequency of Blood Glucose Testing by Diabetics in the U.S.
Exhibit 3.3: Feature Comparison for Leading Brands and Models of Whole Blood Glucose Self-Testing Products
Exhibit 3.4: Other Suppliers of Glucose Self-Testing Products
Exhibit 3.5: Development-Stage Noninvasive/Minimally Invasive Glucose Monitoring Devices
Exhibit 3.6: Worldwide Market for Whole Blood Glucose Self-Testing Products
Exhibit 3.7: Worldwide Market for Whole Blood Glucose Test Strips, Self-Testing Segment
Exhibit 3.8: Worldwide Market for Lancets Used in Whole Blood Glucose Self-Testing
Exhibit 3.9: Worldwide Market for Whole Blood Glucose Self-Testing Products by Region, 2013-2019
Exhibit 3.10: 2014 Worldwide Sales and Market Shares for Leading Suppliers of Whole Blood Glucose Self-Testing Products
Exhibit 3.11: Home Pregnancy and Fertility Tests
Exhibit 3.12: Worldwide Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.13: Worldwide Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.14: Worldwide Market for OTC Fertility Testing Products, 2013-2019
Exhibit 3.15: U.S. Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.16: U.S. Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.17: U.S. Market for OTC Fertility Testing Products, 2014-2019
Exhibit 3.18: European Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.19: European Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.20: European Market for OTC Fertility Testing Products, 2013-2019
Exhibit 3.21: Japan/ROW Market for OTC Pregnancy and Fertility Testing Products, 2013-2019
Exhibit 3.22: Japan/ROW Market for OTC Pregnancy Testing Products, 2013-2019
Exhibit 3.23: Japan/ROW Market for OTC Fertility Testing Products, 2013-2019
Exhibit 3.24: Worldwide Sales and Market Share for the Leading Suppliers of OTC Pregnancy and Fertility Testing Products, 2014
Exhibit 3.25: Worldwide Market for OTC Blood Lipid Testing Products, 2013-2019
Exhibit 3.26: Worldwide Sales and Market Share for the Leading Suppliers of OTC Blood Lipid Testing Products, 2014
Exhibit 3.27: Fecal Occult Blood Testing Products Available in the Global Market
Exhibit 3.28: Worldwide Market for Home Drugs of Abuse Testing Products, 2013-2019
Exhibit 3.29: Worldwide Sales and Market Share for the Leading Suppliers of Home Drugs of Abuse Testing Products, 2014
Exhibit 3.30: INR Self-Testing Products Available in the Global Market
Exhibit 3.31: Worldwide Market for PT/INR Self-Testing Products, 2013-2019
Exhibit 3.32: Worldwide Sales and Market Share for the Leading Suppliers of PT/INR Self-Testing Products, 2014

CHAPTER 4: PHYSICIAN'S OFFICE AND OTHER ALTERNATE SITE TESTING PRODUCTS

4.1 Types of Testing Performed in Physician Offices and Other Alternate Sites
4.2 Existing Physician's Office Laboratory Products
4.3 New POL Products Under Development
4.4 Physician's Office Laboratory Market Analysis
4.5 POL Product Suppliers' Sales and Market Shares
4.6 Drivers and Limiters of the Worldwide POL Products Market
4.7 Other Alternate Site Testing Products and Markets

Exhibit 4.1: Trends in the Number of CLIA-Registered Physician's Office and Other Selected Alternate Site Labs in the U.S.
Exhibit 4.2: Health Care Financing Administration, Center for Laboratories, CLIA Statistics for POLs as of November 2014 (POLs by Certificate Type)
Exhibit 4.3: Tests Ordered by Office-Based Physicians in the U.S., 2000-2006
Exhibit 4.4: Physician's Office Laboratory Products
Exhibit 4.5: New Products Under Development for the POL Market
Exhibit 4.6: Worldwide Market for Physician's Office Laboratory Testing Products, 2013-2019
Exhibit 4.7: Worldwide Market for Physician's Office Laboratory Testing Products by Segment, 2013-2019
Exhibit 4.8: Worldwide Sales and Market Share for the Leading Suppliers of POL Chemistry Products, 2014
Exhibit 4.9: Worldwide Sales and Market Share for the Leading Suppliers of POL Immunodiagnostic Products, 2014
Exhibit 4.10: Worldwide Sales and Market Share for the Leading Suppliers of POL Hematology Products, 2014
Exhibit 4.11: Worldwide Sales and Market Share for the Leading Suppliers of POL Rapid Test Kits, 2014
Exhibit 4.12: Worldwide Sales and Market Share for the Leading Suppliers of POL Urinalysis Products, 2014
Exhibit 4.13: Worldwide Sales and Market Share for the Leading Suppliers of POL Allergy Testing Products, 2014
Exhibit 4.14: Worldwide Sales and Market Share for the Leading Suppliers of POL Whole Blood Glucose Testing Products, 2014
Exhibit 4.15: Worldwide Sales and Market Share for the Leading Suppliers of POL Whole Blood Hemoglobin Testing Products, 2014
Exhibit 4.16: Worldwide Sales and Market Share for the Leading Suppliers of POL Glycated Hemoglobin Testing Products, 2014
Exhibit 4.17: Worldwide Sales and Market Share for the Leading Suppliers of POL Coagulation Testing Products, 2014
Exhibit 4.18: Combined Worldwide Sales and Market Shares of Leading Suppliers of Physician's Office Laboratory Products, 2014

CHAPTER 5: COMPETITOR ASSESSMENT

5.1 Overview of Companies in the Global POC Diagnostics Market
5.2 Mergers and Partnerships to Improve Competitive Position
5.3 Marketing and Distribution Strategies for the Global POC Diagnostics Market

Exhibit 5.1: Overview of Leading Competitors in the POC Diagnostics Market
Exhibit 5.2: Mergers, Acquisitions, and Partnerships Impacting the POC Diagnostics Market

CHAPTER 6: COMPANY PROFILES

6.1 Abaxis
6.2 Abbott Laboratories
6.3 Accriva Diagnostics
6.4 Alere
6.5 Alfa Wassermann
6.6 Arkray
6.7 Bayer Diabetes Care
6.8 Danaher
	6.8.1 Beckman Coulter
	6.8.2 Hemocue
	6.8.3 Radiometer
6.9 Dexcom
6.10 ELITech Group
6.11 Helena Laboratories
6.12 Instrumentation Laboratory
6.13 Menarini Diagnostics
6.14 Nipro Diagnostics
6.15 NOVA Biomedical
6.16 OraSure Technologies
6.17 Ortho Clinical Diagnostics
6.18 Phamatech
6.19 Princeton BioMeditech
6.20 Quidel
6.21 Response Biomedical
6.22 Roche Diagnostics
6.23 Siemens Diagnostics
6.24 Trinity Biotech

APPENDIX - COMPANY LISTING

REFERENCES

COMPANY DIRECTORY


COMPANIES COVERED:

  1. 77 Elektronika Kft.
  2. 3M
  3. A. Menarini Diagnostics
  4. Abaxis Inc.
  5. Abbott
  6. Abbott Architect
  7. Abbott Diagnostics
  8. Abbott Laboratories Inc.
  9. Abbott POC (fka i-STAT)
  10. Abbott Point of Care
  11. ABT GmbH
  12. Access Diagnostic Tests UK Ltd
  13. Accriva Diagnostics
  14. Accumetrics Inc.
  15. AccuTech
  16. ACON Laboratories
  17. Acro Biotech LLC
  18. Adaltis Inc.
  19. Adnavance Technologies
  20. Advantage Diagnostics
  21. Aerscher Diagnostics
  22. AgaMatrix
  23. Aggredyne
  24. AiMedics Pty Ltd.
  25. Akubio
  26. Albertsons (unit of SUPERVALU)
  27. Alere (fka Inverness Medical Innovations)
  28. Alfa Scientific Designs
  29. Alfa Wassermann S.p.A
  30. AllMedicus
  31. Alternecare Health Products
  32. Amazon
  33. American Biomedica Corporation
  34. AmerisourceBergen Corporation
  35. Amgen
  36. Amira Medical
  37. Amylin Pharmaceuticals
  38. Andiatech
  39. ANI Biotech Oy
  40. Apex Biotechnology
  41. Arax Co. Ltd.
  42. Arkray
  43. Arlington Scientific
  44. Arriva
  45. AstraZeneca PLC
  46. Astute Medical
  47. Atlas Link
  48. Audit Diagnostics
  49. Aventir Biotech
  50. AVL List GmbH
  51. AVL Medical
  52. Awareness Technology
  53. Axis-Shield plc
  54. Azo Products
  55. B. Braun Melsungen
  56. Babystart
  57. Ballard Medical (unit of Kimberley-Clark)
  58. Bayer Corporation
  59. Bayer Diabetes Care
  60. Beckman Access
  61. Beckman Coulter
  62. Becton Dickinson
  63. BeneCheck/General Life Biotechnology Co.
  64. Bestgen Biotech
  65. Binax
  66. Bio/Data
  67. BioHelix Corporation
  68. BioMedica Diagnostics
  69. Biomedical Diagnostics Institute National Centre for Sensor Research
  70. Biomedix
  71. Biomerica
  72. bioMerieux
  73. Bionime
  74. Bio-Rad Laboratories
  75. Biosafe Laboratories
  76. Biosite Diagnostics
  77. Biosurfit SA
  78. Biotechnostix
  79. BioTex
  80. BODITECH MED
  81. BodyTel
  82. Boule Diagnostics
  83. Brahms Diagnostica USA
  84. Branan Medical
  85. Calypte Biomedical
  86. Cardinal Health
  87. CardioGenics
  88. CARE Diagnostica
  89. Cepheid Inc.
  90. Ceragem Medisys
  91. CH Werfen/Werfen Life Group
  92. Chek Diagnostics (fka PTS Diagnostics)
  93. Chembio Diagnostic Systems
  94. ChemTrak
  95. Chiron (unit of Novartis)
  96. Cholestech
  97. Church & Dwight
  98. Cigna
  99. Claros Diagnostics
  100. CLIA Waived
  101. Clinical Data
  102. Clinical Genomics
  103. CLONDIAG Chip Technologies GmbH
  104. CoaguSense
  105. Cole Taylor
  106. Concateno plc
  107. Confirm Biosciences
  108. Consult
  109. Corgenix
  110. Coris Bioconcept
  111. Cozart Bioscience Ltd.
  112. CTK Biotech
  113. CVS Caremark
  114. Daiichi Sankyo
  115. Daktari Technologies
  116. Danaher
  117. DexCom
  118. Diabetech
  119. Diagnostic Technology Pty Ltd.
  120. Diagnostic Test Group
  121. Diametrics
  122. Diesse Diagnostica
  123. DNA Direct
  124. Dr. Langer Medical
  125. Drew Scientific
  126. Drucker Diagnostics
  127. Drug Free Enterprises/Express Diagnostics International
  128. EarlyPregnancyTests.com
  129. Echo Therapeutics (fka Sontra Medical)
  130. Edwards Lifesciences
  131. Edwards Medical Supply
  132. EKF Diagnostics
  133. Ekos
  134. Eli Lilly and Company
  135. ELITech Group
  136. Embroytech Labs
  137. Enigma Diagnostics Ltd.
  138. Enterix (unit of Quest Diagnostics)
  139. Epigenomics AG
  140. Epistem
  141. Epocal
  142. EPS Biotechnology
  143. Eumed Biotechnology
  144. Eurolyser Diagnostica
  145. Exact Sciences
  146. F. Hoffmann-La Roche Ltd
  147. Fiomi Diagnostics
  148. First Check
  149. Franklin Diagnostics
  150. Fujirebio Inc.
  151. GDS Technology (unit of Stanbio)
  152. GE Healthcare
  153. GE Medical Systems
  154. GenBio (Innominate)
  155. General Life Biotechnology
  156. Genexo Sp. z o.o.
  157. Gen-Probe
  158. Genzyme
  159. Germaine Laboratories
  160. Germaine Labs
  161. Geron Corporation
  162. GlaxoSmithKline
  163. GlucoLight
  164. Glucostats System Ptd Ltd.
  165. GluMetrics
  166. GlySens
  167. Great Basin Scientific
  168. Grove Instruments
  169. Guangzhou Wondfo Biotech
  170. Haemonetics
  171. Hainice Medical
  172. HandyLab
  173. Healthpia
  174. Heidelberger Medical Marketing
  175. Helena Laboratories, Inc.
  176. Hema Diagnostic Systems
  177. HemoCue AB
  178. HemoSense
  179. HemoSonics LLC
  180. Hemosure/W.H.P.M.
  181. Henry Schein
  182. Hiedelberger Medical Marketing
  183. Hitachi
  184. Hologic
  185. Home Access Health
  186. Home Diagnostics
  187. Home Health Testing
  188. HomeDrugTestingKit.com
  189. Honeywell International
  190. Horiba Ltd.
  191. HuBit
  192. Human Diagnostics
  193. Humasis
  194. Hycor Biomedical (unit of Agilent Technologies)
  195. IDEXX Laboratories
  196. iHealth Labs/Andon Health
  197. iLine Microsystems
  198. Immunostics
  199. Infectio Diagnostic (unit of BD/Geneohm)
  200. Infopia Co. Ltd.
  201. InLight Solutions
  202. InLine Microsystems
  203. Innotrac Diagnostics Oy (unit of Radiometer)
  204. Innovative BioSystems
  205. Inova LAB s.r.l.
  206. Insight Pharmaceuticals
  207. Instant Technologies/Accu-Stat Diagnostics
  208. Instrumentation Laboratory
  209. Insulet
  210. Intec Products
  211. Integrated Nano-Technologies
  212. Integrity Applications
  213. Intel Corporation
  214. IntelliGender
  215. International Immunodiagnostics
  216. International Stem Cell
  217. International Technidyne (Thoratec)
  218. Invacare
  219. Iquum
  220. IRIS Diagnostics
  221. IRIS International
  222. Ischemia Technologies
  223. i-sens
  224. ISIS Pharmaceuticals
  225. Itamar Medical
  226. J. Mitra
  227. Jant Pharmacal
  228. JEI Daniel Biotech
  229. Jhonghe City
  230. Johnson & Johnson
  231. Korea Telecom
  232. Kyoto Daiichi Kagaku Co. (KDK) (unit of Arkray)
  233. LabNOW
  234. Labsystems Diagnostics Oy
  235. Landmark Diagnostics
  236. Lein Applied Diagnostics
  237. LifeHealth
  238. LifeScan
  239. LifeSign/PBM
  240. LighTouch Medical
  241. Lobeck Medical
  242. LRE Relais + Elektronik
  243. Luminous Medical
  244. Magellan Biosciences/ESA
  245. Magellan Diagnostics
  246. Magna BioSciences
  247. Magnetic Diagnostics
  248. Mainline Technology
  249. Mallinckrodt Medical
  250. Masimo
  251. Matria
  252. Maxwell Sensors
  253. MaybeMOM
  254. mBio Diagnostics (division of Precision Photonics)
  255. McKesson
  256. MDY Healthcare Plc (formerly Medisys)
  257. Medarex
  258. Medica
  259. Medical Automation Systems, Inc.
  260. Medi-Lab
  261. Medimmune
  262. Medimpex United
  263. Medline
  264. MedMira
  265. Medonic (unit of Boule Diagnostics/Boule Medical AB)
  266. Medtox Scientific Inc.
  267. Medtronic Blood Management
  268. Medtronic Cardiac Surgery
  269. Medtronic Hemotec
  270. Medtronic Inc.
  271. Menarini
  272. Menarini Diagnostics
  273. Merck & Company
  274. Meridian
  275. Meridian Bioscience
  276. MicroIslet
  277. MicroPoint Bioscience
  278. Mindray Medical International
  279. Mitra
  280. Mitsubishi Chemical
  281. Mitsubishi Kagaku
  282. Moore Medical
  283. Nano Entek
  284. Nano-Ditech
  285. Nanogen
  286. Nanomix
  287. Nanosphere
  288. New Horizons Diagnostics
  289. Nipro Diagnostics
  290. Noble Medical
  291. Northrop Grumman
  292. NOVA Biomedical
  293. Nova Century
  294. Novocell
  295. Omega Pharmaceuticals
  296. OPKO Health
  297. Opti Medical
  298. OptiScan Biomedical
  299. OraSure Technologies Inc.
  300. Oratel Diagnostics
  301. Orgenics
  302. OrSense
  303. Ortho Clinical Diagnostics
  304. Ortho Vitros ES
  305. Ortho-Clinical Diagnostics
  306. Osmetech
  307. Oxoid (unit of Thermo Fisher Scientific)
  308. Panasonic Shikoku Electronics
  309. Paradigm Health
  310. PATH (Program for Appropriate Technology in Health)
  311. Permaxim
  312. Pfizer
  313. Phadia
  314. Phamatech
  315. Pharmanetics
  316. Philips Healthcare
  317. Polymedco
  318. Polymer Technology Systems
  319. Preventx
  320. Princeton
  321. Princeton BioMeditech Corporation
  322. Procter & Gamble
  323. Prodesse
  324. PSS World Medical
  325. QBC Diagnostics/The Drucker Company
  326. Qualigen
  327. Quest Diagnostics
  328. Quidel, Inc.
  329. Radiometer International A/S
  330. Redwood Biotech (unit of Inverness Medical)
  331. ReLIA Biotechnologies
  332. ReLIA Diagnostic Systems
  333. Remel (unit of Thermo Fisher Scientific)
  334. ReNeuron Group
  335. Response Biomedical
  336. Rite-Aid
  337. Roche
  338. Roche Diagnostics (fka Boehringer Mannheim Diagnostics)
  339. Rohto Pharmaceutical
  340. Royal Philips Electronics
  341. SA Scientific
  342. Sacks Medical
  343. Samsung
  344. Sanitoets Closed Corp/Sallamander Concepts
  345. Sanvita
  346. Sanwa Kaguku Kenkyusho
  347. Schering Plough
  348. SD Biosensor
  349. Sekisui
  350. Select Diagnostics
  351. SenDx Medical
  352. Senseonics
  353. Sensile Medical
  354. Sensors for Medicine and Science
  355. Separation Technology
  356. Seradyn
  357. Sichuan Maker Biotechnology
  358. Siemens
  359. Siemens Diagnostics (fka Dade Behring)
  360. Silicon BioDevices
  361. Siloam
  362. Socrates Health Solutions
  363. Sparton
  364. Spectral Diagnostics Inc.
  365. Spectral Medical, Inc.
  366. Stanbio Laboratory
  367. Stanbio/Alere
  368. Standard Diagnostics
  369. Stem Cells Inc.
  370. Swiss Precision Diagnostics
  371. Synova
  372. Syntron
  373. Sysmex
  374. T2 Biosystems
  375. Taidoc
  376. Takeda Pharmaceutical
  377. Target
  378. Techno Medica Co. Ltd.
  379. Teco Diagnostics
  380. TEM International
  381. Terumo
  382. The Carlyle Group
  383. The McDevitt Research Group
  384. Thermo Biostar
  385. Thermo Fisher Scientific Inc.
  386. Thoratec
  387. ThromboVision
  388. Tianjin New Bay Bioresearch
  389. TKNO
  390. Tosoh
  391. Tosoh AIA
  392. Trinity Biotech
  393. TwistDx
  394. Tyson Bioresearch
  395. U.S. Diagnostics
  396. UCP Biosciences
  397. Veralight
  398. Visgeneer
  399. Visual Pathways
  400. Vital Diagnostics
  401. Vivacta
  402. VivoMedical
  403. VolitionRx Ltd.
  404. Walgreen Company
  405. Walmart Stores
  406. Wampole Laboratories
  407. X-Bar Diagnostic Systems
  408. YD Diagnostics
  409. Yellow Springs Instruments, Inc.
  410. YSI
  411. Yu.Sys
  412. Zetek
Contact Us

Need help finding medtech research? Let us help you!